Approval based on results of landmark Phase 3 C-POST trial that show Libtayo is first immunotherapy to significantly improve disease-free ...

The European Commission has approved Libtayo (cemiplimab) as the first and only immunotherapy for adult patients with ...

Regeneron Pharmaceuticals has won expanded European approval of its blockbuster cancer drug Libtayo for certain patients with skin cancer. Regeneron on Wednesday said the European Commission's nod ...

Researchers have uncovered that SerpinB3, typically linked to severe cancers, is also a key player in natural wound healing.

Stage 2 vaginal cancer involves spread beyond the vaginal wall but not to the pelvic sidewall, with symptoms like abnormal ...

A new large-scale study suggests that a simple, over-the-counter vitamin could play a major role in preventing skin cancer.

Regeneron gains EC approval to expand Libtayo's use in high-risk CSCC. The FDA approves Eylea HD the treatment of patients with macular edema following retinal vein occlusion.

When a routine blood test shows high levels of a protein called SerpinB3, it often alerts doctors that something is seriously wrong. Elevated SerpinB3 ...